Should I buy or sell ICU Medical stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ICUI shares. View ICUI analyst ratings or view top-rated stocks .

What is ICU Medical's stock price target for 2024?

2 analysts have issued 12 month target prices for ICU Medical's stock. Their ICUI share price targets range from $110.00 to $136.00. On average, they expect the company's share price to reach $123.00 in the next year. This suggests a possible upside of 26.7% from the stock's current price. View analysts price targets for ICUI or view top-rated stocks among Wall Street analysts .

How have ICUI shares performed in 2024?

ICU Medical's stock was trading at $99.74 at the start of the year. Since then, ICUI shares have decreased by 2.6% and is now trading at $97.10. View the best growth stocks for 2024 here .

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024. View our ICUI earnings forecast .

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) issued its earnings results on Tuesday, February, 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.39. The medical instruments supplier had revenue of $587.86 million for the quarter, compared to analysts' expectations of $564.77 million. ICU Medical had a positive trailing twelve-month return on equity of 6.35% and a negative net margin of 1.31%.

What ETFs hold ICU Medical's stock?

ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH) , SPDR S&P Health Care Equipment ETF (XHE) and Principal Healthcare Innovators ETF (BTEC) . Vanguard S&P Small-Cap 600 Value ETF (VIOV) .

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of 4.400-5.100 for the period, compared to the consensus estimate of 5.180. The company issued revenue guidance of -.

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com . Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX) , BlackRock (BLK) , NVIDIA (NVDA) , Alibaba Group (BABA) , Xtrackers California Municipal Bond ETF (CA) , UnitedHealth Group (UNH) , Boeing (BA) , Micron Technology (MU) , Lockheed Martin (LMT) and ServiceNow (NOW) .

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different institutional and retail investors. Top institutional investors include GAMMA Investing LLC (0.00%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney , George A Lopez , Virginia Ruth Sanzone and Vivek Jain . View institutional ownership trends .

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:ICUI

ICU Medical (ICUI) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

Free ICUI Stock Alerts

$97.10

-1.10 (-1.12%)

(As of 04/15/2024 ET)

Compare

Today's Range: $96.62
▼
$99.60
50-Day Range: $95.00
▼
$112.48
52-Week Range: $78.28
▼
$212.43

Volume: 208,407 shs
Average Volume: 263,828 shs
Market Capitalization: $2.37 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $123.00

Get ICU Medical alerts:

ICU Medical MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 26.7% Upside
$123.00 Price Target
Short Interest: Healthy
4.71% of Float Sold Short
Dividend Strength: N/A
Sustainability: -1.47
Upright™ Environmental Score
News Sentiment: 0.74
Based on 5 Articles This Week
Insider Trading: Selling Shares
$2.55 M Sold Last Quarter
Proj. Earnings Growth: 52.84%
From $3.52 to $5.38 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.48 out of 5 stars

Medical Sector

96th out of 929 stocks

Surgical & Medical Instruments Industry

15th out of 97 stocks

3.5

Analyst's Opinion

Consensus Rating
ICU Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
ICU Medical has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
4.71% of the float of ICU Medical has been sold short.
Short Interest Ratio / Days to Cover
ICU Medical has a short interest ratio ("days to cover") of 3.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in ICU Medical has recently increased by 3.24%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
ICU Medical does not currently pay a dividend.
Dividend Growth
ICU Medical does not have a long track record of dividend growth.

3.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
ICU Medical has received a 52.01% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Intravenous therapy equipment", "Catheters", and "Parenteral (intravenous) nutrition formulations" products. See details.
Environmental Sustainability
The Environmental Impact score for ICU Medical is -1.47.

2.1

News and Social Media Coverage

News Sentiment
ICU Medical has a news sentiment score of 0.74. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for ICU Medical this week, compared to 2 articles on an average week.
Search Interest
Only 1 people have searched for ICUI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
MarketBeat Follows
Only 3 people have added ICU Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ICU Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,545,532.00 in company stock.
Percentage Held by Insiders
Only 6.70% of the stock of ICU Medical is held by insiders.
Percentage Held by Institutions
96.10% of the stock of ICU Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for ICU Medical are expected to grow by 52.84% in the coming year, from $3.52 to $5.38 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of ICU Medical is -78.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of ICU Medical is -78.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
ICU Medical has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

About ICU Medical Stock (NASDAQ:ICUI)

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

ICUI Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ICUI Stock News Headlines

March 17, 2024 | insidertrades.com

Daniel Woolson Sells 791 Shares of ICU Medical, Inc. (NASDAQ:ICUI) Stock

April 12, 2024 | finance.yahoo.com

Shareholders in ICU Medical (NASDAQ:ICUI) are in the red if they invested five years ago

April 16, 2024 | InvestorPlace (Ad)

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

April 10, 2024 | msn.com

Country-rap star in ICU and ‘steadily improving’ after post-concert heart attack

April 10, 2024 | msn.com

Family caregivers can help shape the outcomes for their loved ones—an ICU nurse explains their vital role

April 8, 2024 | americanbankingnews.com

ICU Medical (NASDAQ:ICUI) vs. NEXGEL (NASDAQ:NXGL) Head to Head Contrast

March 20, 2024 | finance.yahoo.com

ICUI Apr 2024 60.000 put

March 17, 2024 | morningstar.com

ICU Medical Inc ICUI

April 16, 2024 | InvestorPlace (Ad)

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

March 17, 2024 | finance.yahoo.com

ICUI Apr 2024 80.000 put

March 16, 2024 | finance.yahoo.com

ICUI Apr 2024 125.000 call

March 16, 2024 | ca.finance.yahoo.com

ICUI Apr 2024 120.000 call

March 13, 2024 | globenewswire.com

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum

March 4, 2024 | ca.finance.yahoo.com

ICUI Mar 2024 50.000 call

March 3, 2024 | finance.yahoo.com

ICUI Mar 2024 110.000 put

March 2, 2024 | finanznachrichten.de

ICU Medical, Inc.: ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance

March 1, 2024 | globenewswire.com

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference

March 1, 2024 | finance.yahoo.com

Earnings Update: ICU Medical, Inc. (NASDAQ:ICUI) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

February 28, 2024 | msn.com

ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday

February 28, 2024 | markets.businessinsider.com

KeyBanc Reaffirms Their Buy Rating on ICU Medical (ICUI)

February 28, 2024 | finance.yahoo.com

Zacks.com featured highlights include ICU Medical and Ardmore Shipping

February 28, 2024 | finance.yahoo.com

ICU Medical, Inc. (NASDAQ:ICUI) Q4 2023 Earnings Call Transcript

February 27, 2024 | markets.businessinsider.com

ICU Medical Q4 Earnings Summary

February 27, 2024 | finance.yahoo.com

ICU Medical Inc (ICUI) Posts Mixed Q4 Results; Provides 2024 Guidance

February 27, 2024 | globenewswire.com

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance

February 26, 2024 | markets.businessinsider.com

ICU Medical earnings preview: what Wall Street is expecting

February 26, 2024 | msn.com

ICU Medical Q4 2023 Earnings Preview

See More Headlines

Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/27/2024
Today: 4/15/2024
Next Earnings (Estimated): 5/13/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: Health Care Supplies
Current Symbol: NASDAQ:ICUI
CUSIP: 44930G10
CIK: 883984
Web: www.icumed.com
Phone: (949) 366-2183
Fax: 949-366-8368
Employees: 14,000
Year Founded: 1984

Price Target and Rating

Average Stock Price Target: $123.00
High Stock Price Target: $136.00
Low Stock Price Target: $110.00
Potential Upside/Downside: +26.7%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.23)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 27.59
P/E Growth: N/A
Net Income: $-29,660,000.00
Net Margins: -1.31%
Pretax Margin: -3.47%
Return on Equity: 6.35%
Return on Assets: 3.03%

Debt

Debt-to-Equity Ratio: 0.74
Current Ratio: 2.53
Quick Ratio: 1.06

Sales & Book Value

Annual Sales: $2.26 billion
Price / Sales: 1.05
Cash Flow: $15.15 per share
Price / Cash Flow: 6.41
Book Value: $87.96 per share
Price / Book: 1.10

Miscellaneous

Outstanding Shares: 24,360,000
Free Float: 22,733,000
Market Cap: $2.37 billion
Optionable: Optionable
Beta: 0.69

Social Links

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Mr. Vivek Jain (Age 52)
CEO & Chairman of the Board
Comp: $1.16M
Mr. Brian Michael Bonnell (Age 50)
CFO & Treasurer
Comp: $618.92k
Mr. Christian B. Voigtlander (Age 56)
Chief Operating Officer
Comp: $651.42k
Ms. Virginia Ruth Sanzone (Age 49)
Corporate VP, General Counsel, Secretary & Compliance Officer
Comp: $552.73k

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ICUI Stock Analysis - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ICUI shares.
View ICUI analyst ratings or view top-rated stocks.
What is ICU Medical's stock price target for 2024?: 2 analysts have issued 12 month target prices for ICU Medical's stock. Their ICUI share price targets range from $110.00 to $136.00. On average, they expect the company's share price to reach $123.00 in the next year. This suggests a possible upside of 26.7% from the stock's current price.
View analysts price targets for ICUI or view top-rated stocks among Wall Street analysts.
How have ICUI shares performed in 2024?: ICU Medical's stock was trading at $99.74 at the start of the year. Since then, ICUI shares have decreased by 2.6% and is now trading at $97.10.
View the best growth stocks for 2024 here.
When is ICU Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our ICUI earnings forecast.
How were ICU Medical's earnings last quarter?: ICU Medical, Inc. (NASDAQ:ICUI) issued its earnings results on Tuesday, February, 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.39. The medical instruments supplier had revenue of $587.86 million for the quarter, compared to analysts' expectations of $564.77 million. ICU Medical had a positive trailing twelve-month return on equity of 6.35% and a negative net margin of 1.31%.
What ETFs hold ICU Medical's stock?: ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE) and Principal Healthcare Innovators ETF (BTEC).Vanguard S&P Small-Cap 600 Value ETF (VIOV).

What guidance has ICU Medical issued on next quarter's earnings?: ICU Medical updated its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of 4.400-5.100 for the period, compared to the consensus estimate of 5.180. The company issued revenue guidance of -.
What is Vivek Jain's approval rating as ICU Medical's CEO?: 81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.
What other stocks do shareholders of ICU Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), Xtrackers California Municipal Bond ETF (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).
Who are ICU Medical's major shareholders?: ICU Medical's stock is owned by many different institutional and retail investors. Top institutional investors include GAMMA Investing LLC (0.00%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney, George A Lopez, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends.
How do I buy shares of ICU Medical?: Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ICUI) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial